Cathy Eng/X
Jan 28, 2025, 08:28
Cathy Eng: Creating a new standard of care with Checkmate 8HW
Cathy Eng, VICC Associate Director of Strategic Relations and Research Partnerships at Vanderbilt-Ingram Cancer Center, posted the following on X:
“Checkmate 8HW: Nivo +/- ipi in metastatic dMMR (MSI-H) with superior PFS vs. nivo alone (39.3M vs. NR, HR = 0.62, p-value = 0.0003), creating a NEW standard of care; RR = 71% vs. 58% (p = 0.0011). Med f/U ~4 years.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 24, 2025, 23:27
Feb 24, 2025, 15:25
Feb 24, 2025, 14:55
Feb 24, 2025, 14:51
Feb 24, 2025, 14:45
Feb 24, 2025, 14:22
Feb 24, 2025, 14:08
Feb 24, 2025, 14:00
Feb 24, 2025, 13:59
Feb 24, 2025, 13:47